<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="platform">4</item><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="id">3450</item><item key="factors"><item><item key="GSM460255"><item key="CELL LINE">A2780</item><item key="CELL TYPE">adenocarcinoma ovary</item><item key="TREATMENT">Untreated</item></item></item><item><item key="GSM460255"><item key="CELL LINE">A2780</item><item key="CELL TYPE">adenocarcinoma ovary</item><item key="TREATMENT">Untreated</item></item></item><item><item key="GSM460255"><item key="CELL LINE">A2780</item><item key="CELL TYPE">adenocarcinoma ovary</item><item key="TREATMENT">Untreated</item></item></item><item><item key="GSM460258"><item key="CELL LINE">A2780</item><item key="CELL TYPE">adenocarcinoma ovary</item><item key="TREATMENT">CDk-125</item></item></item><item><item key="GSM460258"><item key="CELL LINE">A2780</item><item key="CELL TYPE">adenocarcinoma ovary</item><item key="TREATMENT">CDk-125</item></item></item><item><item key="GSM460258"><item key="CELL LINE">A2780</item><item key="CELL TYPE">adenocarcinoma ovary</item><item key="TREATMENT">CDk-125</item></item></item><item><item key="GSM46026"><item key="CELL LINE">A2780</item><item key="CELL TYPE">adenocarcinoma ovary</item><item key="TREATMENT">CDk-509</item></item></item><item><item key="GSM46026"><item key="CELL LINE">A2780</item><item key="CELL TYPE">adenocarcinoma ovary</item><item key="TREATMENT">CDk-509</item></item></item><item><item key="GSM46026"><item key="CELL LINE">A2780</item><item key="CELL TYPE">adenocarcinoma ovary</item><item key="TREATMENT">CDk-509</item></item></item><item><item key="GSM460255"><item key="CELL LINE">A2780</item><item key="CELL TYPE">adenocarcinoma ovary</item><item key="TREATMENT">Untreated</item></item></item><item><item key="GSM460255"><item key="CELL LINE">A2780</item><item key="CELL TYPE">adenocarcinoma ovary</item><item key="TREATMENT">Untreated</item></item></item><item><item key="GSM461096"><item key="CELL LINE">A2780</item><item key="CELL TYPE">adenocarcinoma ovary</item><item key="TREATMENT">CDK-887</item></item></item><item><item key="GSM461096"><item key="CELL LINE">A2780</item><item key="CELL TYPE">adenocarcinoma ovary</item><item key="TREATMENT">CDK-887</item></item></item><item><item key="GSM461114"><item key="CELL LINE">MCF7</item><item key="CELL TYPE">adenocarcinoma mammary cells</item><item key="TREATMENT">untreated</item></item></item><item><item key="GSM461114"><item key="CELL LINE">MCF7</item><item key="CELL TYPE">adenocarcinoma mammary cells</item><item key="TREATMENT">untreated</item></item></item><item><item key="GSM461116"><item key="CELL LINE">MCF7</item><item key="CELL TYPE">adenocarcinoma mammary cells</item><item key="TREATMENT">CDK-125</item></item></item><item><item key="GSM461116"><item key="CELL LINE">MCF7</item><item key="CELL TYPE">adenocarcinoma mammary cells</item><item key="TREATMENT">CDK-125</item></item></item><item><item key="GSM461152"><item key="CELL LINE">A2780</item><item key="CELL TYPE">adenocarcinoma ovary</item><item key="TREATMENT">untreated</item></item></item><item><item key="GSM461152"><item key="CELL LINE">A2780</item><item key="CELL TYPE">adenocarcinoma ovary</item><item key="TREATMENT">untreated</item></item></item><item><item key="GSM461154"><item key="CELL LINE">A2780</item><item key="CELL TYPE">adenocarcinoma ovary</item><item key="TREATMENT">Flavopiridol</item></item></item><item><item key="GSM461154"><item key="CELL LINE">A2780</item><item key="CELL TYPE">adenocarcinoma ovary</item><item key="TREATMENT">Flavopiridol</item></item></item><item><item key="GSM461114"><item key="CELL LINE">MCF7</item><item key="CELL TYPE">adenocarcinoma mammary cells</item><item key="TREATMENT">untreated</item></item></item><item><item key="GSM461114"><item key="CELL LINE">MCF7</item><item key="CELL TYPE">adenocarcinoma mammary cells</item><item key="TREATMENT">untreated</item></item></item><item><item key="GSM49003"><item key="CELL LINE">MCF7</item><item key="CELL TYPE">adenocarcinoma mammary cells</item><item key="TREATMENT">17AAG</item></item></item><item><item key="GSM49003"><item key="CELL LINE">MCF7</item><item key="CELL TYPE">adenocarcinoma mammary cells</item><item key="TREATMENT">17AAG</item></item></item><item><item key="GSM490033"><item key="CELL LINE">MCF7</item><item key="CELL TYPE">adenocarcinoma mammary cells</item><item key="TREATMENT">AUY922</item></item></item><item><item key="GSM490033"><item key="CELL LINE">MCF7</item><item key="CELL TYPE">adenocarcinoma mammary cells</item><item key="TREATMENT">AUY922</item></item></item><item><item key="GSM490035"><item key="CELL LINE">MCF7</item><item key="CELL TYPE">adenocarcinoma mammary cells</item><item key="TREATMENT">CDK-887</item></item></item><item><item key="GSM490035"><item key="CELL LINE">MCF7</item><item key="CELL TYPE">adenocarcinoma mammary cells</item><item key="TREATMENT">CDK-887</item></item></item><item><item key="GSM490037"><item key="CELL LINE">MCF7</item><item key="CELL TYPE">adenocarcinoma mammary cells</item><item key="TREATMENT">doxorubicin</item></item></item><item><item key="GSM490037"><item key="CELL LINE">MCF7</item><item key="CELL TYPE">adenocarcinoma mammary cells</item><item key="TREATMENT">doxorubicin</item></item></item><item><item key="GSM490039"><item key="CELL LINE">MCF7</item><item key="CELL TYPE">adenocarcinoma mammary cells</item><item key="TREATMENT">E973</item></item></item><item><item key="GSM490039"><item key="CELL LINE">MCF7</item><item key="CELL TYPE">adenocarcinoma mammary cells</item><item key="TREATMENT">E973</item></item></item><item><item key="GSM49004"><item key="CELL LINE">MCF7</item><item key="CELL TYPE">adenocarcinoma mammary cells</item><item key="TREATMENT">SN38</item></item></item><item><item key="GSM49004"><item key="CELL LINE">MCF7</item><item key="CELL TYPE">adenocarcinoma mammary cells</item><item key="TREATMENT">SN38</item></item></item></item><item key="ownerprofile_id">arrayexpress_sid</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-18552</item><item key="summary_wrapped">This SuperSeries is composed of the following subset Series: GSE18486: CDK inhibitors PHA-848125 and PHA-690509 profiling on A2780...</item><item key="pubmed_id">20679242</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">3</item><item key="sample_count">35</item><item key="tags"><item>cell</item><item>line</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">cdk-inhibitors-and-flavopiridol-profiling-on-a2780</item><item key="geo_id_plat">E-GEOD-18552_A-AFFY-44</item><item key="name">CDK inhibitors and flavopiridol profiling on A2780 and MCF7 cells</item><item key="created">Sep.15, 2014</item><item key="summary">This SuperSeries is composed of the following subset Series: GSE18486: CDK inhibitors PHA-848125 and PHA-690509 profiling on A2780 GSE18498: CDK inhibitor PHA-793887 profiling on A2780 GSE18501: CDK inhibitor PHA-848125 gene expression profiling on MCF7 cell line GSE18504: Flavopiridol profiling on A2780 GSE19638: Compounds profiling on MCF7 Refer to individual Series</item><item key="geo_gse_id">E-GEOD-18552</item><item key="species">human</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-18552/samples/</item></data></biogps>
